Pharmacological Analysis of GABAA Receptor and Sigma1R Chaperone Interaction: Research Report I―Investigation of the Anxiolytic, Anticonvulsant and Hypnotic Effects of Allosteric GABAA Receptors’ Ligands
International Journal of Molecular Sciences · 31.05.2023 · 24 (11) · 9580
DOI: 10.3390/ijms24119580 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.05.2023. Verfasst von Mikhail V Voronin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacogenetics, Federal State Budgetary Institution "Research Zakusov Institute of Pharmacology", Baltiyskaya Street 8, 125315 Moscow…. Hauptthemen laut MEDLINE: Anti-Anxiety Agents, Receptors, GABA-A. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Two groups of facts have been established in previous drug development studies of the non-benzodiazepine anxiolytic fabomotizole. First, fabomotizole prevents stress-induced decrease in binding ability of the GABAA receptor’s benzodiazepine site. Second, fabomotizole is a Sigma1R chaperone agonist, and exposure to Sigma1R antagonists blocks its anxiolytic effect. To prove our main hypothesis of Sigma1R involvement in GABAA receptor-dependent pharmacological effects, we performed a series of experiments on BALB/c and ICR mice using Sigma1R ligands to study anxiolytic effects of benzodiazepine tranquilizers diazepam (1 mg/kg i.p.) and phenazepam (0.1 mg/kg i.p.) in the elevated plus maze test, the anticonvulsant effects of diazepam (1 mg/kg i.p.) in the pentylenetetrazole-induced seizure model, and the hypnotic effects of pentobarbital (50 mg/kg i.p.). Sigma1R antagonists BD-1047 (1, 10, and 20 mg/kg i.p.), NE-100 (1 and 3 mg/kg i.p.), and Sigma1R agonist PRE-084 (1, 5, and 20 mg/kg i.p.) were used in the experiments. Sigma1R antagonists have been found to attenuate while Sigma1R agonists can enhance GABAARs-dependent pharmacological effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacogenetics, Federal State Budgetary Institution "Research Zakusov Institute of Pharmacology", Baltiyskaya Street 8, 125315 Moscow, Russia.
ORCID-Profile: Mikhail V Voronin, Svetlana A Litvinova, Elena V Abramova, Rustam D Kurbanov, Yulia V Vakhitova, Sergei B Seredenin
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Voronin, M. V., Shangin, S. V., Litvinova, S. A., Abramova, E. V., Kurbanov, R. D., Rybina, I. V., Vakhitova, Y. V., & Seredenin, S. B. (2023). Pharmacological Analysis of GABAA Receptor and Sigma1R Chaperone Interaction: Research Report I―Investigation of the Anxiolytic, Anticonvulsant and Hypnotic Effects of Allosteric GABAA Receptors’ Ligands. International Journal of Molecular Sciences, 24(11), 9580. https://doi.org/10.3390/ijms24119580
Vancouver
Voronin MV, Shangin SV, Litvinova SA, Abramova EV, Kurbanov RD, Rybina IV, et al. Pharmacological Analysis of GABAA Receptor and Sigma1R Chaperone Interaction: Research Report I―Investigation of the Anxiolytic, Anticonvulsant and Hypnotic Effects of Allosteric GABAA Receptors’ Ligands. International Journal of Molecular Sciences. 2023;24(11):9580. doi:10.3390/ijms24119580
BibTeX
@article{Voronin2023,
author = {Voronin, Mikhail V and Shangin, Stanislav V and Litvinova, Svetlana A and Abramova, Elena V and Kurbanov, Rustam D and Rybina, Inna V and Vakhitova, Yulia V and Seredenin, Sergei B},
title = {Pharmacological Analysis of GABAA Receptor and Sigma1R Chaperone Interaction: Research Report I―Investigation of the Anxiolytic, Anticonvulsant and Hypnotic Effects of Allosteric GABAA Receptors’ Ligands},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {11},
pages = {9580},
doi = {10.3390/ijms24119580}
}
EUVIMED